Functional Imaging of Neuroendocrine Tumors: Stacking the Odds in a Patient's Favor
Overview
Overview
Journal
J Clin Endocrinol Metab
Publisher
Oxford University Press
Specialty
Endocrinology
Date
2022 May 10
PMID
35536703
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pacak K, Taieb D, Lin F, Jha A J Clin Endocrinol Metab. 2024; 109(9):2366-2388.
PMID: 38652045 PMC: 11319006. DOI: 10.1210/clinem/dgae252.
New Biology of Pheochromocytoma and Paraganglioma.
Pacak K Endocr Pract. 2022; 28(12):1253-1269.
PMID: 36150627 PMC: 9982632. DOI: 10.1016/j.eprac.2022.09.003.
References
1.
Jha A, Taieb D, Carrasquillo J, Pryma D, Patel M, Millo C
. High-Specific-Activity-I-MIBG versus Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res. 2021; 27(11):2989-2995.
PMC: 8172462.
DOI: 10.1158/1078-0432.CCR-20-3703.
View
2.
Borgna F, Haller S, Monne Rodriguez J, Ginj M, Grundler P, Zeevaart J
. Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging. 2021; 49(4):1113-1126.
PMC: 8921065.
DOI: 10.1007/s00259-021-05564-0.
View
3.
Refardt J, Hofland J, Wild D, Christ E
. Molecular Imaging of Neuroendocrine Neoplasms. J Clin Endocrinol Metab. 2022; 107(7):e2662-e2670.
DOI: 10.1210/clinem/dgac207.
View
4.
Imperiale A, Meuter L, Pacak K, Taieb D
. Imaging of Small Intestine Neuroendocrine Neoplasms: Is SSTR PET the Holy Grail?. J Nucl Med. 2021; 62(10):1347-1348.
PMC: 8724890.
DOI: 10.2967/jnumed.121.262140.
View
5.
Wang Y, Xu Y, Kan Y, Wang W, Yang J
. Diagnostic Value of Seven Different Imaging Modalities for Patients with Neuroblastic Tumors: A Network Meta-Analysis. Contrast Media Mol Imaging. 2021; 2021:5333366.
PMC: 8429030.
DOI: 10.1155/2021/5333366.
View